Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones

Blood

Volumn 93, Issue 1, 1999, Pages 251-259

  Van De Corput, Lisette ^a   Kluin Nelemans, Hanneke C ^a   Kester, Michel G D ^a   Willemze, Roel ^a   Falkenburg, J H Frederik ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; PHYTOHEMAGGLUTININ;

ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIMED LYMPHOCYTE TYPING; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0032910548     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.1.251.401k03_251_259     Document Type: Article

References (53)

1. Cawley JC, Burns GF, Hayhoe FJG: Hairy Cell Leukemia. Berlin, Germany, Springer-Verlag, 1980, p 85
2. Golomb HM, Hadad LJ: Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol 16:393, 1984
3. Kluin-Nelemans JC: Hairy cell leukemia and its T cell interactions. Leuk Lymphoma 4:159, 1991
4. Knight RA, Worman CP, Cawley JC: Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukemia. Clin Exp Immunol 53:600, 1983
5. Kluin-Nelemans JC, Kester MGD, Oving I, Cluitmans FHM, Willemze R, Falkenburg JHF: Abnormally activated T lymphocytes in the spleen of patients with hairy cell leukemia. Leukemia 8:2095, 1994
6. + cells expressing Vγ9Vδ2, which normally predominate the blood, are found in the spleens of patients with hairy cell leukemia. Leukemia 11:106, 1997
7. Corput van de L, Falkenburg JHF, Kluin-Nelemans JC: T cell dysfunction in hairy cell leukemia: An updated review. Leuk Lymphoma 30:31, 1998
8. Kluin-Nelemans JC, Kester MGD, Melenhorst JJ, Landegent JE, van de Corput L, Willemze R, Falkenburg JHF: Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 87:3795, 1996
9. Mueller DL, Jenkins M: Molecular mechanisms underlying functional T cell unresponsiveness. Curr Opin Immunol 7:375, 1995
10. Schwartz RH: Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 184:1, 1996
11. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 367:425, 1994
12. Sharpe AH: Analysis of lymphocyte costimulation in vivo using transgenic and 'knock out' mice. Curr Opin Immunol 7:389, 1995
13. Planken EV, Dijkstra NH, Bakkus MH, Willemze R, Kluin-Nelemans JC: Proliferation of precursor B-lineage acute lymphoblastic leukemia (ALL) by activating the CD40 antigen. Br J Haematol 95:319, 1996
14. Faber MF, Luxemburg-Heijs van SAP, Willemze R, Falkenburg JHF: Generation of leukemia-reactive cytotoxic lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 176:1283, 1992
15. Uytdehaag FGCM, Loggen HG, Logtenberg T, Lichtveld RA, van Steenis B, van Asten JAAM, Osterhaus ADME: Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertypic cross-reacting neutralizing antibody on in vitro stimulation with one type of poliovirus. J Immunol 135:3094, 1985
16. Roelen DL, Datema G, van Bree FPMJ, Zhang L, van Rood JJ, Claas FHJ: Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen. Transplantation 53:899, 1992
17. Barnstable CJ, Bodmer WF, Brown G, Galfre GG, Milstein C, Williams AF, Ziegler A: Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9, 1978
18. Koning F, Schreuder I, Bontrop R, de Vries P, Giphart M, Termijtelen A, Bruning H: A monoclonal antibody with MT2 specifity. Dis Markers 2:75, 1984
19. Terstappen LWMM, Shah VO, Conrad MP, Recktenwald D, Loken MR: Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry 9:477, 1988
20. Kluin-Nelemans JC, Kester MGD, van de Corput L, Boor PPC, Landegent JE, van Dongen JJM, Willemze R, Falkenburg JHF: Correction of abnormal T cell receptor repertoire during interferon-α therapy in patients with hairy cell leukemia. Blood 91:4224, 1998
21. Cluitmans FHM, Esendam BHJ, Landegem JE, Willemze R, Falkenburg JHF: Regulatory effects of T cell lymphokines on cytokine gene expression in monocytes. Lymphokine Cytokine Res 12:457, 1993
22. + subsets of T lymphocytes in monozygotic twins. J Immunol 150:2033, 1993
23. Struyk L, Kurnick JT, Hawes GE, Laar van JM, Schipper R, Okseriberg JR, Steinman L, de Vries RR, Breedveld FC, Elsen van den P: T cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. Hum Immunol 37:237, 1993
24. Lindemann A, Ludwig WD, Oster W, Mertelsmann R, Hermann F: High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 73:880, 1989
25. Buck C, Digel W, Schoniger W, Stefanic M, Rachavachar A, Porzsolt F: Tumor necrosis factor and hairy cell leukemia. Lancet 2:402, 1988
26. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754. 1993
27. Taga K, Mostowski H, Tosato G: Human interleukin-10 can directly inhibit T cell growth. Blood 81:2964, 1993
28. + T cells. J Exp Med 184:19, 1996
29. - T cells in hairy cell leukemia. Keystone Symposia, Cellular Immunology and the Immunotherapy of Cancer-III, Copper Mountain, CO, 1997 (abstr)
30. Jansen JH, Harst van der D, Wientjens GHM, Kooy-Winkelaar YMC, Brand A, Willemze R, Kluin-Nelemans JC: Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibilty to T-cell but not lymphokine-activated killer-cell cytotoxicity. Blood 80:478, 1992
31. Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Agostini C, Semenzato G: B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res 57:4940, 1997
32. Cardoso AA, Schulze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM: Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88:41, 1996
33. Cardoso AA, Seamon MJ, Afonso HM, Ghia P, Boussiotis VA, Freeman GJ, Gribben JG, Sallan SE, Nadler LM: Ex vivo generation of human anti-pre-B-leukemia-specific autologous cytolytic T cells. Blood 90:549, 1997
34. Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ. Glickman-Nir E, Sippel KC, Rogers J, Cleary AM, Parker M, Chess L, Lederman S: T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol 153:666, 1994
35. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925, 1993
36. Kooten van C, Banchereau J: Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9:330, 1997
37. Van Den Hove LE, Van Gool SW, Vandenberghe P, Bakkus M, Thielemans K, Boogaerts MA, Ceuppens JL: CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 11:572, 1997
38. Kwok WW, Nepom GT, Raymond FC: HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 155:2468, 1995
39. Kwok WW, Domeier ME, Johnson ML, Nepom GT, Koelle DM: HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med 183:1253, 1996
40. Castellino F, Zhong G, Germain RN: Antigen Presentation by MHC class II molecules: Invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum Immunol 54:159, 1997
41. Corradin G, Demotz S: Peptide-MHC complexes assembled following multiple pathways: An opportunity for the design of vaccines and therapeutic molecules. Hum Immunol 54:137, 1997
42. Nelson CA, Vidavsky I, Viner NJ, Gross ML, Unanue ER: Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 94:628, 1997
43. Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, Brasseur F, Lethé B. Jotereau F, Boon T: A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J Exp Med 183:1173, 1996
44. Boon T, Coulie PG, Van de Eynde B: Tumor antigens recognized by T cells. Immunol Today 18:267, 1997
45. Boon T, Bruggen van der P: Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725, 1996
46. + T cell subsets in chronic lymphocytic leukemia. J Immunol 158:1482, 1997
47. Wen T, Mellstedt H, Jondal M: Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma. J Exp Med 171:659, 1990
48. Shi I, Bonnefoix T, Heuzé-Le Vacon F, Jacob M-C, Leroux D, Gressin R, Sotto M-F, Chaffanjon P, Bensa J-C, Sotto J-J: Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas. Br J Haematol 90:837, 1995
49. + T cells in patients with multiple myeloma and paraproteinemia. Blood 87:3297, 1996
50. + T cell expansions are found preferentially in patients with low tumor burden. Eur J Immunol 27:2245. 1997
51. Sherman W, Liu Z, Inghirami G, Reed EF, Harris FPE, Suciu-Foca NM: Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specifc T cells. Immunol Res 12:338, 1993
52. Farace F, Orlanducci F, Dietrich P-Y, Gaudin C, Angevin E, Courtier M-H, Bayle C, Hercend T, Triebel F: T cell repertoire in patients with B chronic lymphocytic leukemia: Evidence for multiple in vivo T cell clonal expansions. J Immunol 153:4281, 1994
53. Dietrich P-Y, Walker PR, Schnuriger V, Saas P, Perrin G, Guillard M. Gaudin C, Caignard A: TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture. Int Immunol 9:1073, 1997